Longitudinal study of myelin basic protein-specific T-cell receptors during the course of multiple sclerosis

Journal of Neuroimmunology

Volumn 78, Issue 1-2, 1997, Pages 162-171

  Lovett Racke, Amy E ^a,b   Martin, Roland ^a   McFarland, Henry F ^a   Racke, Michael K ^b   Utz, Ursula ^c  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Complementarity determining region 3; Magnetic resonance imaging; Multiple Sclerosis; Myelin basic protein; T cell receptor

Indexed keywords

GADOLINIUM; MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR;

ANTIGEN SPECIFICITY; ARTICLE; BLOOD BRAIN BARRIER; CELL INFILTRATION; ENVIRONMENTAL FACTOR; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; LONGITUDINAL STUDY; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; T LYMPHOCYTE ACTIVATION;

ADULT; AMINO ACID SEQUENCE; BASE SEQUENCE; EPITOPES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 0030803681     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00097-0     Document Type: Article

References (44)

1. Acha-Orbea H., Mitchell D.H., Timmermann L., Wraith D.C., Tausch G.S., Waldor M.K., Zamvil S.S., McDevitt H.O., Steinman L. Limited heterogeneity of T-cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell. 54:1988;263-273.
2. Arden B., Clark S.P., Kabelitz D., Mak T.W. Human T-cell receptor variable gene segment families. Immunogenetics. 42:1995;455-500.
3. Bell R.B., Lindsey J.W., Sobel R.A., Hodgkinson S., Steinman L. Diverse T-cell receptor Vβ gene usage in the central nervous system in experimental allergic encephalomyelitis. J. Immunol. 150:1993;4085-4092.
4. Ben-Nun A., Liblau R.S., Cohen L., Lehman D., Tournier-Lasserve E., Rosenzweig A., Jingwu Z., Raus J.C., Bach M.-A. Restricted T-cell receptor Vβ gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: Predominant genes vary in individuals. Proc. Natl. Acad. Sci. USA. 88:1991;2466-2470.
5. Burns F.R., Li X., Shen N., Offner H., Chou Y.K., Vandenbark A.A., Heber-Katz E. Both rat and mouse T-cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar Vα and Vβ chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different. J. Exp. Med. 169:1989;27-39.
6. Chirgwin J.M., Przybala A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched with ribonuclease. Biochemistry. 18:1979;5294-5299.
7. Detels R., Visscher B.R., Haile R.W., Malmgren R.M., Dudley J.P., Coulson A.H. Multiple sclerosis and age at migration. Am. J. Epidemiol. 108:1978;386-393.
8. Hafler D.A., Saadeh M.G., Kuchroo V.K., Milford E., Steinman L. TCR usage in human and experimental demyelinating disease. Immunol. Today. 17:1996;152-159.
9. Harris J.O., Frank J.O., Patronas N., McFarlin D.E., McFarland H.F. Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: Implication for clinical trials and natural history. Ann. Neurol. 29:1991;548-555.
10. Hashim G.A., Vandenbark A.A., Galang A.B., Diamanduros T., Carvalho E., Srinivasan J., Jones R., Vainiene M., Morrison W.J., Offner H. Antibodies specific for Vβ8 receptor peptide suppress experimental autoimmune encephalomyelitis. J. Immunol. 144:1990;4621-4627.
11. Howell M.D., Winters S.T., Olee T., Powell H.C., Carlo D.J., Brostoff S.W. Vaccination against experimental allergic encephalomyelitis with T-cell receptor peptides. Science. 246:1989;668-670.
12. Multiple Sclerosis Collaborative Research Group, Jacobs L.D., Cookfair D.L., Rudick R.A., Herndon R.M., Richert J.R., Salazar A.M., Fischer J.S., Goodkin D.E., Granger C.V., Simon J.H., Alam J.J., Bartoszak D.M., Bourdette D.S., Braiman J., Brownscheild C.M., Coats M.E., Cohan S.L., Dougherry D.S., Kinkel R.P., Mass M.K., Munschauer F.E., Priore R.L., Pullincino P.M., Scherokman B.J., Guttman B.W., Whitham R.H. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann. Neurol. 39:1996;285-294.
13. James, S.P., 1994. Measurement of basic immunologic characteristics of human mononuclear cells. In: Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M., Strober, W. (Eds.), Current Protocols in Immunology. Current Protocols, New York, pp. 7.10.1-10.
14. Joshi N., Usuku K., Hauser S.L. The T-cell response to myelin basic protein in familial multiple sclerosis: Diversity of fine specificity, restricting elements and T-cell receptor usage. Ann. Neurol. 34:1993;385-393.
15. Kotzin B.L., Karuturi S., Chou Y.K., Lafferty J., Forrester J.M., Better M., Nedwin G.E., Offner H., Vandenbark A.A. Preferential T-cell receptor β-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA. 88:1991;9161-9165.
16. Kurtzke J.F., Hyllested K. Multiple sclerosis in the Faroe islands. 1. Clinical and epidemiological features. Ann. Neurol. 5:1979;6-21.
17. Martin R., Jaraquemada D., Flerlage M., Richert J., Whitaker J., Long E.O., McFarlin D.E., McFarland H.F. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T-cell lines from multiple sclerosis patients and healthy individuals. J. Immunol. 145:1990;540-548.
18. Martin R., Howell M.D., Jaraquemada D., Flerlage M., Richert J., Brostoff S., Long E.O., McFarlin D.E., McFarland H.F. A myelin basic protein peptide is recognized by cytotoxic T-cells in the context of four HLA-DR types associated with multiple sclerosis. J. Exp. Med. 173:1991;19-24.
19. + cytotoxic T-cell response specific for the immunodominant myelin basic protein peptide 87-106. J. Immunol. 148:1992;1359-1366.
20. Martin R., McFarland H.F., McFarlin D.E. Immunological aspects of demyelinating diseases. Ann. Rev. Immunol. 10:1992;153-187.
21. Offner H., Hashim G.A., Vandenbark A.A. T-cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science. 251:1991;430-432.
22. Oksenberg J.R., Panzara M.A., Begovich A.B., Mitchell D., Erlich H.A., Murray R.S., Shimonkevitz R., Sherritt M., Rothbard J., Bernard C.C.A., Steinman L. Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature. 362:1993;68-70.
23. Orita M., Iwahana H., Kanazawa H., Hayashi K., Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA. 86:1989;2766-2770.
24. Ota K., Matsui M., Milford E.L., Mackin G.A., Weiner H.L., Hafler D.A. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 346:1990;183-187.
25. Raine C. Analysis of autoimmune demyelination: Its impact upon multiple sclerosis. Lab. Invest. 50:1984;608-635.
26. Richert J.R., Robinson E.D., Camphausen K., Martin R., Voskuhl R.R., Faerber M.A., McFarland H.F., Hurley C.K. Diversity of T-cell receptor V alpha, V beta and CDR3 expression by myelin basic protein-specific human T-cell clones. Neurology. 45:1995;1919-1922.
27. Schumacher G.A., Beebe G., Kibler R.F., Kurland L.T., Kurtke J.F., McDowell F., Nagler B., Sibley W.A., Tourtellotte W.W., Willmon T.L. Problems of experimental trials of therapy in multiple sclerosis: Report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann. N.Y. Acad. Sci. 122:1965;552-568.
28. The IFNB Multiple Sclerosis Study Group Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology. 43:1993;655-661.
29. Urban J.L., Kumar V., Kono D.H., Gomez C., Horvath S.J., Clayton J., Ando D.G., Servarz E.E., Hood L. Restricted use of T-cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell. 54:1988;577-592.
30. Utz U., Biddison W.E., McFarland H.F., McFarlin D.E., Flerlage M., Martin R. Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis. Nature. 364:1993;243-247.
31. Utz U., Brooks J.A., McFarland H.F., Martin R., Biddison W.E. Heterogeneity of T-cell receptor α-chain complementarity-determining region 3 in myelin basic protein-specific T-cells increases with severity of multiple sclerosis. Proc. Natl. Acad. Sci. USA. 91:1994;5567-5571.
32. + cytotoxic T lymphocytes from patients with HTLV-1-associated disease: Evidence for oligoclonal expansion. J. Virol. 70:1996;843-851.
33. Vandenbark A.A., Hashim G., Offner H. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature. 341:1989;541-544.
34. Vandenbark A.A., Chou Y.K., Whitham R., Mass M., Buenafe A., Liefeld D., Kavanagh D., Cooper S., Hashim G.A., Offner H., Bourdette D.N. Treatment of multiple sclerosis with T-cell receptor peptides: Results of a double-blind pilot trial. Nature Med. 2:1996;1109-1115.
35. Vandevyver C., Mertens N., van den Elsen P., Medaer R., Raus J., Zhang J. Clonal expansion of myelin basic protein-reactive T-cells in patients with multiple sclerosis: Restricted T-cell receptor V gene rearrangements and CDR3 sequence. Eur. J. Immunol. 25:1995;958-968.
36. Vergelli M., Hemmer B., Utz U., Vogt A., Kalbus M., Tranquill L., Conlon P., Ling N., Steinman L., McFarland H.F., Martin R. Differential activation of human autoreactive T-cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99). Eur. J. Immunol. 11:1996;2624-2634.
37. Wucherpfennig K.W., Ota K., Endo N., Seidman J.G., Rosenzweig A., Weiner H.L., Hafler D.A. Shared human T-cell receptor Vβ usage to immunodominant regions of myelin basic protein. Science. 248:1990;1016-1019.
38. Wucherpfennig K.W., Zhang J., Witek C., Matsui M., Modabber Y., Ota K., Hafler D.A. Clonal expansion and persistence of human T-cells specific for an immunodominant myelin basic protein peptide. J. Immunol. 152:1994;5581-5592.
39. Wucherpfennig K.W., Hafler D.A., Strominger J.L. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: Positioning of T-cell receptors on HLA-DR2/peptide complexes. Proc. Natl. Acad. Sci. USA. 92:1995;8896-8900.
40. Yamamoto K., Sakoda H., Nakajima H., Kato T., Okubo M., Dohi M., Mizushima Y., Ito K., Nishioka K. Accumulation of multiple T-cell clonotype in the synovial lesions of patients with rheumatoid arthritis revealed by a novel clonality analysis. Int. Immunol. 4:1992;1219-1223.
41. Zaller D.M., Osman G., Kanagawa O., Hood L. Prevention and treatment of murine experimental allergic encephalomyelitis with T-cell receptor Vβ-specific antibodies. J. Exp. Med. 171:1990;1943-1955.
42. Zamvil S.S., Mitchell D.J., Lee N.E., Moore A.C., Waldor M.K., Sakai K., Rothbard J.B., McDevitt H.O., Steinman L., Acha-Orbea H. Predominant expression of a T-cell receptor Vβ gene subfamily in autoimmune encephalomyelitis. J. Exp. Med. 167:1988;1586-1596.
43. Zhang J.W., Medaer R., Chin Y., van den Berg-Loonen E., Raus J.C.M. Myelin basic protein-specific T-lymphocytes in multiple sclerosis and controls: Precursor frequency, fine specificity and cytotoxicity. Ann. Neurol. 32:1992;330-339.
44. Zhang J., Markovic-Plese S., Lacet B., Raus J., Weiner H.L., Hafler D.A. Increased frequency of interleukin 2-responsive T-cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179:1994;973-984.